Is US Physicalrapy Stock a Good Investment?
US Physicalrapy Investment Advice | USPH |
- Examine US Physicalrapy's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research US Physicalrapy's leadership team and their track record. Good management can help US Physicalrapy navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact US Physicalrapy's business and its evolving consumer preferences.
- Compare US Physicalrapy's performance and market position to its competitors. Analyze how US Physicalrapy is positioned in terms of product offerings, innovation, and market share.
- Check if US Physicalrapy pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about US Physicalrapy's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in US Physicalrapy stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if US Physicalrapy is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine US Physicalrapy Stock
Researching US Physicalrapy's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 98.0% of the company outstanding shares are owned by institutional investors. The book value of US Physicalrapy was at this time reported as 32.73. The company last dividend was issued on the 23rd of May 2025. US Physicalrapy had 3:2 split on the 29th of June 2001.
To determine if US Physicalrapy is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding US Physicalrapy's research are outlined below:
| US Physicalrapy generated a negative expected return over the last 90 days | |
| Over 98.0% of the company outstanding shares are owned by institutional investors | |
| On 11th of April 2025 US Physicalrapy paid $ 0.45 per share dividend to its current shareholders | |
| Latest headline from zacks.com: Is the Options Market Predicting a Spike in U.S. Physical Therapy Stock |
US Physicalrapy Quarterly Cash And Short Term Investments |
|
US Physicalrapy uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in US Physicalrapy. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to US Physicalrapy's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact US Physicalrapy's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises US Physicalrapy's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2001-03-09 | 2000-12-31 | 0.09 | 0.1 | 0.01 | 11 | ||
1999-08-05 | 1999-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
1997-05-13 | 1997-03-31 | 0.03 | 0.04 | 0.01 | 33 | ||
1996-11-06 | 1996-09-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2005-10-27 | 2005-09-30 | 0.18 | 0.2 | 0.02 | 11 | ||
2005-04-28 | 2005-03-31 | 0.15 | 0.17 | 0.02 | 13 | ||
2002-05-01 | 2002-03-31 | 0.18 | 0.16 | -0.02 | 11 | ||
2000-11-08 | 2000-09-30 | 0.08 | 0.1 | 0.02 | 25 |
US Physicalrapy Target Price Consensus
USPH target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. US Physicalrapy's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Strong Buy |
Most USPH analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand USPH stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of US Physicalrapy, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationUS Physicalrapy Target Price Projection
US Physicalrapy's current and average target prices are 77.25 and 108.33, respectively. The current price of US Physicalrapy is the price at which US Physicalrapy is currently trading. On the other hand, US Physicalrapy's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
US Physicalrapy Market Quote on 14th of May 2025
Target Price
Analyst Consensus On US Physicalrapy Target Price
US Physicalrapy Analyst Ratings
US Physicalrapy's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about US Physicalrapy stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of US Physicalrapy's financials, market performance, and future outlook by experienced professionals. US Physicalrapy's historical ratings below, therefore, can serve as a valuable tool for investors.Know US Physicalrapy's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as US Physicalrapy is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading US Physicalrapy backward and forwards among themselves. US Physicalrapy's institutional investor refers to the entity that pools money to purchase US Physicalrapy's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Gw&k Investment Management, Llc | 2024-12-31 | 316.2 K | Envestnet Asset Management Inc | 2024-12-31 | 299.8 K | Riverbridge Partners Llc | 2025-03-31 | 283.3 K | Northern Trust Corp | 2024-12-31 | 261.8 K | Bahl & Gaynor Inc. | 2024-12-31 | 260.1 K | Point72 Asset Management, L.p. | 2024-12-31 | 212.9 K | Silvercrest Asset Management Group Llc | 2024-12-31 | 189.1 K | Rockefeller Capital Management L.p. | 2024-12-31 | 188.3 K | Fmr Inc | 2024-12-31 | 165.7 K | Blackrock Inc | 2024-12-31 | 2.3 M | Vanguard Group Inc | 2024-12-31 | 1.1 M |
US Physicalrapy's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.17 B.Market Cap |
|
US Physicalrapy's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.08 | 0.12 | |
| Return On Capital Employed | 0.06 | 0.06 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.05 | 0.08 |
Determining US Physicalrapy's profitability involves analyzing its financial statements and using various financial metrics to determine if US Physicalrapy is a good buy. For example, gross profit margin measures US Physicalrapy's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of US Physicalrapy's profitability and make more informed investment decisions.
Evaluate US Physicalrapy's management efficiency
US Physicalrapy has return on total asset (ROA) of 0.0402 % which means that it generated a profit of $0.0402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0663 %, meaning that it created $0.0663 on every $100 dollars invested by stockholders. US Physicalrapy's management efficiency ratios could be used to measure how well US Physicalrapy manages its routine affairs as well as how well it operates its assets and liabilities. As of now, US Physicalrapy's Return On Tangible Assets are decreasing as compared to previous years. The US Physicalrapy's current Return On Equity is estimated to increase to 0.08, while Return On Capital Employed is projected to decrease to 0.06. As of now, US Physicalrapy's Non Currrent Assets Other are decreasing as compared to previous years. The US Physicalrapy's current Intangible Assets is estimated to increase to about 188.3 M, while Other Current Assets are projected to decrease to under 6.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 50.39 | 52.91 | |
| Tangible Book Value Per Share | (5.80) | (5.51) | |
| Enterprise Value Over EBITDA | 18.30 | 19.21 | |
| Price Book Value Ratio | 2.73 | 4.65 | |
| Enterprise Value Multiple | 18.30 | 19.21 | |
| Price Fair Value | 2.73 | 4.65 | |
| Enterprise Value | 144.3 M | 151.5 M |
Effective leadership at US Physicalrapy drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Basic technical analysis of USPH Stock
As of the 14th of May 2025, US Physicalrapy owns the Mean Deviation of 1.47, standard deviation of 2.06, and Risk Adjusted Performance of (0.12). Concerning fundamental indicators, the technical analysis model makes it possible for you to check potential technical drivers of US Physicalrapy, as well as the relationship between them.US Physicalrapy's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific US Physicalrapy insiders, such as employees or executives, is commonly permitted as long as it does not rely on US Physicalrapy's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases US Physicalrapy insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
US Physicalrapy's Outstanding Corporate Bonds
US Physicalrapy issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. US Physicalrapy uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most USPH bonds can be classified according to their maturity, which is the date when US Physicalrapy has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Understand US Physicalrapy's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing US Physicalrapy's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (0.19) | |||
| Mean Deviation | 1.47 | |||
| Coefficient Of Variation | (1,361) | |||
| Standard Deviation | 2.06 | |||
| Variance | 4.26 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.07) | |||
| Treynor Ratio | (0.20) | |||
| Maximum Drawdown | 9.63 | |||
| Value At Risk | (2.57) | |||
| Potential Upside | 2.41 | |||
| Skewness | 0.3596 | |||
| Kurtosis | 2.42 |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (0.19) | |||
| Mean Deviation | 1.47 | |||
| Coefficient Of Variation | (1,361) | |||
| Standard Deviation | 2.06 | |||
| Variance | 4.26 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.07) | |||
| Treynor Ratio | (0.20) | |||
| Maximum Drawdown | 9.63 | |||
| Value At Risk | (2.57) | |||
| Potential Upside | 2.41 | |||
| Skewness | 0.3596 | |||
| Kurtosis | 2.42 |
Consider US Physicalrapy's intraday indicators
US Physicalrapy intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of US Physicalrapy stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
US Physicalrapy Corporate Filings
8K | 13th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 9th of May 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
| 24th of April 2025 Other Reports | ViewVerify | |
| 11th of April 2025 Other Reports | ViewVerify |
USPH Stock media impact
There is far too much social signal, news, headlines, and media speculation about US Physicalrapy that are available to investors today. This information is accessible both publicly - through US Physicalrapy's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of USPH-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of US Physicalrapy news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of US Physicalrapy relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to US Physicalrapy's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive US Physicalrapy alpha.
US Physicalrapy Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards US Physicalrapy can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
US Physicalrapy Historical Investor Sentiment
Investor biases related to US Physicalrapy's public news can be used to forecast risks associated with an investment in USPH. The trend in average sentiment can be used to explain how an investor holding USPH can time the market purely based on public headlines and social activities around US Physicalrapy. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
US Physicalrapy's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for US Physicalrapy and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average US Physicalrapy news discussions. The higher the estimate score, the more favorable the investor's outlook on US Physicalrapy.
US Physicalrapy Corporate Directors
| Mark Brookner | Independent Director | Profile | |
| Kathleen Gilmartin | Independent Director | Profile | |
| Clayton Trier | Independent Director | Profile | |
| Bernard Harris | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.716 | Dividend Share 1.77 | Earnings Share 2.18 | Revenue Per Share | Quarterly Revenue Growth 0.181 |
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between US Physicalrapy's value and its price, as these two are different measures arrived at by various means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.